Vimarsana
Biggest News Aggregation in the World

Page 25 - Johnson Medtech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Johnson Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Johnson Medtech Today - Breaking & Trending Today

Vision Stories Shed Light on Importance of Eye Health - The Pagosa Springs Sun - Vimarsana News

Vision Stories Shed Light on Importance of Eye Health - The Pagosa Springs Sun

(BPT) - Around the world, about 1 billion people suffer from eye conditions that could be prevented or need to be addressed1. For instance, cataracts are the leading cause of preventable blindness …

Johnson & Johnson MedTech Acquires Laminar, Inc. - Vimarsana News

Johnson & Johnson MedTech Acquires Laminar, Inc.

Innovative investigational device designed for Left Atrial Appendage Elimination to reduce the risk of stroke in patients with non-valvular atrial fibrillation Strengthens position in high-growth...

Johnson & Johnson enters LAA device space with Laminar buy - Vimarsana News

Johnson & Johnson enters LAA device space with Laminar buy

Johnson & Johnson MedTech announced today that it completed the acquisition of left atrial appendage (LAA) device maker Laminar.

Johnson & Johnson MedTech Completes Laminar Acquisition, Sees $0.15/share Negative Impact In FY24 - Vimarsana News

Johnson & Johnson MedTech Completes Laminar Acquisition, Sees $0.15/share Negative Impact In FY24

Healthcare major Johnson & Johnson (JNJ) announced on Thursday that its unit Johnson & Johnson MedTech has completed the acquisition of Laminar, Inc., a privately held medical devices company.

Laminar, Inc. Acquired by Johnson & Johnson Medtech for $400 Million Upfront with Additional Clinical and Regulatory Milestone Payments in 2024 and Beyond - Vimarsana News

Laminar, Inc. Acquired by Johnson & Johnson Medtech for $400 Million Upfront with Additional Clinical and Regulatory Milestone Payments in 2024 and Beyond

/PRNewswire/ -- Santé Ventures (Santé), an early-stage healthcare and life sciences investment firm, has announced the acquisition of its Fund III portfolio...